Under Emasol range of products, Emami will manufacture and market five offerings.
It posted the matter for further hearing after two weeks.
HUL called Emami's threats of legal action 'groundless.'
The product addresses the basic need of a consumer to build immunity from within.
The agency will be responsible for creating digital ideas
